We first examined publicly available datasets (kmplot.com) of patients with different subtypes of breast cancer (ER+/−, PR+/−, and HER2+/−), regardless of age at diagnosis or treatment status, for ANCO1 mRNA expression levels. The gene discussed is ERBB2; the disease is breast carcinoma.